Past briefings

Monday, October 19, 2026

The top medical stories of the day, as they ran.

Morning edition

7 stories

  1. 1CDC sends scientist to help Pennsylvania respond to measles outbreakOutbreaks · 2 outlets
  2. 2FDA approves Enspryng as an at-home treatment for thyroid eye diseaseDrugs and FDA · 3 outlets
  3. 3FDA approves Brytly eye drops for nonprescription redness reliefDrugs and FDA · 3 outlets
  4. 4CMS proposes Medicare Advantage directory scores and PBM rulesMedicare and Medicaid · 2 outlets
  5. 5FDA warns of counterfeit eye drops found in Florida and GeorgiaDrug safety · 1 outlet
  6. 6AMA releases governance framework for agentic AI in healthcareHealth policy · 2 outlets
  7. 7Pope Leo returns to Vatican after lung cancer surgeryCancer · 2 outlets

Evening edition

11 stories

  1. 1Trump orders NIH women’s health division and White House task forceHealth policy · 5 outlets
  2. 2Kenya reports eight Ebola infections after another patient tests positiveOutbreaks · 3 outlets
  3. 3Models project more chronic hepatitis B infections under delayed newborn vaccinationVaccines · 3 outlets
  4. 4Ebola outbreak in Congo reaches an eighth provinceOutbreaks · 2 outlets
  5. 5Gilead’s oral ulcerative colitis drug shows stronger remission rates than EntyvioResearch · 2 outlets
  6. 6FDA approves dostarlimab for some patients with locally advanced rectal cancerDrugs and FDA · 2 outlets
  7. 7FDA expands Ryzumvi approval to treat presbyopiaDrugs and FDA · 1 outlet
  8. 8Merck KGaA agrees to acquire Silence Therapeutics and its RNA drug pipelineIndustry · 3 outlets
  9. 9FDA warns about Edwards SAPIEN M3 delivery systems after balloon burstsMedical devices · 1 outlet
  10. 10Diabetes conversation cards improved clinician satisfaction but not care fitDiabetes and obesity · 2 outlets
  11. 11Nativity and US Residence Duration and Colorectal Cancer Screening NonadherenceResearch · 2 outlets

This Week in Medicine

This Week in Medicine

The week’s top stories, the recalls worth knowing, and a moment from medical history. Every Sunday.

Free. No spam. Unsubscribe anytime.